Featured Research

from universities, journals, and other organizations

Proteins conspire to make breast cancer cells resistant to drug treatment

Date:
April 18, 2014
Source:
Sanford-Burnham Medical Research Institute
Summary:
The interaction between two proteins called BCAR1 and BCAR3 is responsible for resistance to antiestrogen drugs, paving the way for improved diagnostic and treatment strategies. “Drug resistance is one of the most serious obstacles to breast cancer eradication,” said the senior study author. “Our findings suggest that strategies to disrupt the BCAR1-BCAR3 complex and associated signaling networks could potentially overcome this obstacle and ultimately lead to more-effective breast cancer therapies.”

Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) provide compelling and conclusive evidence that antiestrogen resistance in breast cancer cells requires the interaction between proteins called BCAR1 and BCAR3. In the study, published in the Journal of Biological Chemistry, the researchers also identified a signaling pathway that is crucial for drug resistance mediated by this protein complex.

"Drug resistance is one of the most serious obstacles to breast cancer eradication," said senior study author Elena Pasquale, Ph.D., professor in the National Cancer Institute-designated Cancer Center and the Tumor Initiation and Maintenance Program at Sanford-Burnham. "Our findings suggest that strategies to disrupt the BCAR1-BCAR3 complex and associated signaling networks could potentially overcome this obstacle and ultimately lead to more-effective breast cancer therapies."

Breast cancer is the most common cancer in women in the United States, and despite advances in treatment strategies, about 10 percent of these patients die within five years of being diagnosed. One major factor contributing to these deaths is the development of intrinsic or acquired resistance to antiestrogen drugs, which interfere with the ability of the hormone estrogen to stimulate the growth of breast cancer cells. Two proteins implicated in antiestrogen resistance and malignancy are breast cancer antiestrogen resistance proteins 1 and 3 (BCAR1 and BCAR3), which can bind together to potentially connect the signaling pathways they each regulate. Indeed, the levels of BCAR1-BCAR3 complexes are more closely associated with malignancy compared with the levels of each individual protein. But a few studies have cast doubt on the importance of the BCAR1-BCAR3 complex in regulating breast cancer aggressiveness.

A few years ago, when a group of researchers generated a mutation in an amino acid that mediates binding between BCAR1 and BCAR3, the breast cancer cells still exhibited antiestrogen resistance, suggesting that the BCAR1-BCAR3 complex is not required for drug resistance.

However, Pasquale and her team subsequently found that single amino acid mutations at BCAR1-BCAR3 binding sites may not be sufficient to adequately disrupt the formation of the protein complex, possibly because two separate binding sites work together to generate a very strong interaction between these proteins. "Based on our data, we suspected that the BCAR mutations used in previous studies did not sufficiently block the formation of the BCAR1-BCAR3 complex and disrupt downstream signaling pathways, leaving the role of this protein complex in drug resistance an open question," Pasquale said.

To unambiguously answer this question in the new study, Pasquale and her team collaborator Stefan Riedl, Ph.D., associate professor in Sanford-Burnham's NCI-designated Cancer Center, generated mutations in two amino acids of BCAR3 to effectively disrupt the interaction between the two proteins. Consistent with previous findings, a single amino acid mutation in BCAR3 did not prevent the protein from interacting with BCAR1 and did not interfere with the growth of breast cancer cells treated with an antiestrogen drug. By contrast, this drug inhibited the growth of breast cancer cells expressing the double mutant BCAR3, suggesting that the BCAR1-BCAR3 complex is required for antiestrogen resistance.

The researchers also found that antiestrogen resistance mediated by the BCAR1-BCAR3 complex depends on ERK1/2 signaling, which was previously implicated in breast cancer malignancy. ERK1/2 stands for extracellular-signal-regulated kinase 1 and 2, and carries out activation and signaling tasks between molecules and cells. Moreover, analysis of more than 400 tumors from an invasive breast cancer study revealed that higher levels of an ERK1/2-inhibiting protein called PEA15 were predictive of longer patient survival.

On the other hand, the antiestrogen drug did not stymie the growth of breast cancer cells that were genetically modified to express high levels of a BCAR3-related protein called NSP3, suggesting that this protein also promotes drug resistance. "Taken together, our findings suggest that NSP3 and PEA15 protein levels could represent useful new prognostic indicators, in conjunction with BCAR1-BCAR3 and ERK1/2 signaling," Pasquale said.

In addition to improving diagnostic approaches, the findings could have important implications for treatment strategies. "The fact that the BCAR1-BCAR3 interaction is remarkably tight and modifications that substantially weaken it are not sufficient to impair many of the functional effects of the protein complex suggests that inhibiting downstream signaling pathways may be a more viable therapeutic approach," Pasquale said. "In particular, inhibiting ERK1/2 activity through PEA15 may be a useful strategy to counteract breast cancer malignancy and resistance to chemotherapeutic agents."


Story Source:

The above story is based on materials provided by Sanford-Burnham Medical Research Institute. The original article was written by Susan Gammon. Note: Materials may be edited for content and length.


Journal Reference:

  1. Y. Wallez, S. J. Riedl, E. B. Pasquale. Association of the Breast Cancer Antiestrogen Resistance Protein 1 (BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance. Journal of Biological Chemistry, 2014; 289 (15): 10431 DOI: 10.1074/jbc.M113.541839

Cite This Page:

Sanford-Burnham Medical Research Institute. "Proteins conspire to make breast cancer cells resistant to drug treatment." ScienceDaily. ScienceDaily, 18 April 2014. <www.sciencedaily.com/releases/2014/04/140418161329.htm>.
Sanford-Burnham Medical Research Institute. (2014, April 18). Proteins conspire to make breast cancer cells resistant to drug treatment. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2014/04/140418161329.htm
Sanford-Burnham Medical Research Institute. "Proteins conspire to make breast cancer cells resistant to drug treatment." ScienceDaily. www.sciencedaily.com/releases/2014/04/140418161329.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins